Publication: 4414

Genomic characterisation and prognostic significance of HER2-low, hormone receptor-positive, early breast cancers from the BIG 1-98 and SOFT clinical trials
      QxMD      Google Scholar   
Citation:
JCO Precis Oncol vol 9 e2400599.
Year:
2025
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub-ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Pfizer  
Grants:
U10CA180821, CA075362, NHMRC grant 351161, 510788, 1105058  
Corr. Author:
 
Authors:
                                 
Networks:
LAPS-IL057, NC002, OH070, UPSTATE   
Study
Multiple Studies, or Legacy Studies in Alliance Study:
IBCSG-24-02 (SOFT-TEXT), BIG I-98
Phases:
3
Keywords: